Get the Stockscreener App
0.761
7.18%
0.051
Xtant Medical Holdings Inc stock is traded at $0.761, with a volume of 2,769.
It is up +7.18% in the last 24 hours and up +23.54% over the past month.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers various products to treat a range of spinal and sacroiliac conditions, including trauma, degeneration, deformity, and tumor. Xtant Medical Holdings, Inc. markets its products through direct sales, consignment agents, reseller distributors, private label distributors, and technology licensees. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
See More
Previous Close:
$0.71
Open:
$0.7181
24h Volume:
2,769
Relative Volume:
0.01
Market Cap:
$103.14M
Revenue:
$78.46M
Net Income/Loss:
$2.75M
P/E Ratio:
76.10
EPS:
0.01
Net Cash Flow:
$-12.42M
1W Performance:
-1.42%
1M Performance:
+23.54%
6M Performance:
+10.00%
1Y Performance:
+48.29%
1-Day Range:
$0.7181
$0.7367
1-Week Range:
$0.70
$0.8099
52-Week Range:
$0.3401
$0.95
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Name
Xtant Medical Holdings Inc
Sector
Industry
Phone
406-388-0480
Address
664 Cruiser Lane, Belgrade, MT
Compare XTNT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XTNT
Xtant Medical Holdings Inc
|
0.7367 | 99.40M | 78.46M | 2.75M | -12.42M | 0.01 |
|
ABT
Abbott Laboratories
|
128.41 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.54 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.37 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.75 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.69 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-23 | Initiated | BTIG Research | Buy |
| Nov-15-18 | Reiterated | Maxim Group | Buy |
| Feb-14-18 | Reiterated | Maxim Group | Buy |
Xtant Medical Holdings Inc Stock (XTNT) Latest News
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Crosses Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Can GPT Healthcare Limited Regain Lost Ground This QuarterMarket Depth Overview & Low Cost Portfolio Growth - bollywoodhelpline.com
Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Up 286.3% in December - MarketBeat
Aro Granite Industries Limited Bounces Off Moving Average SupportMACD Trading Signals & Rapid Capital Gain - earlytimes.in
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Will Xtant Medical Holdings Inc. (XMS) stock remain on Wall Street radarBuy Signal & Smart Money Movement Tracker - Улправда
Published on: 2025-12-20 11:07:26 - Улправда
Aug Decliners: Will Xtant Medical Holdings Inc. stock beat EPS estimatesJuly 2025 Movers & Fast Gaining Stock Strategy Reports - Улправда
Signal Recap: Will Xtant Medical Holdings Inc. stock beat EPS estimatesWeekly Trend Report & Real-Time Market Sentiment Alerts - Улправда
Is Xtant Medical Holdings Inc. stock a dividend growth opportunity2025 Support & Resistance & Daily Stock Trend Reports - DonanımHaber
History Review: How Xtant Medical Holdings Inc. stock performs in weak economyJuly 2025 Price Swings & Smart Money Movement Tracker - DonanımHaber
Published on: 2025-12-19 12:58:44 - Улправда
Aug Weekly: Is Xtant Medical Holdings Inc. (XMS) stock a momentum leaderShort Setup & Free Daily Entry Point Trade Alerts - Улправда
Published on: 2025-12-18 14:07:33 - Улправда
Analysts Offer Insights on Healthcare Companies: Xtant Medical Holdings (XTNT), Novan (NOVN) and Adaptive Biotechnologies (ADPT) - The Globe and Mail
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
AWM Investment Company Inc. Takes $4.88 Million Position in Xtant Medical Holdings, Inc. $XTNT - MarketBeat
Xtant Medical (NYSEAMERICAN:XTNT) Share Price Passes Above 200-Day Moving AverageHere's What Happened - MarketBeat
Xtant Medical Debuts Next-Gen Synthetic Bone Graft - Precedence Research
Xtant Medical launches next-generation synthetic bone graft - Investing.com
Xtant Medical launches next-generation synthetic bone graft By Investing.com - Investing.com South Africa
Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata Synthetic Bone Graft - Finviz
Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata™ Synthetic Bone Graft - Morningstar
Tangible book value per share of Xtant Medical Holdings, Inc. – DUS:XMS - TradingView — Track All Markets
Growth Value: Is Xtant Medical Holdings Inc stock a defensive play in 2025Quarterly Trade Review & Daily Technical Forecast Reports - moha.gov.vn
Xtant Medical Approves Equity Plan Amendment at Meeting - MSN
Will Xtant Medical Holdings Inc. stock beat revenue estimatesWeekly Trend Recap & High Accuracy Swing Trade Signals - Newser
How Xtant Medical Holdings Inc. (XMS) stock valuation compares with sectorMarket Movement Recap & Fast Entry Momentum Alerts - Newser
XTNT SEC FilingsXtant Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Xtant Medical Sells Assets to Companion Spine - TipRanks
Xtant Medical (XTNT) completes Coflex/CoFix and Paradigm divestitures, prepays $8M term debt - Stock Titan
Is Xtant Medical Holdings Inc. (XMS) stock worth buying before Fed actionPortfolio Performance Report & Verified Chart Pattern Signals - Newser
Will Xtant Medical Holdings Inc. (XMS) stock keep high P E multiplesShare Buyback & AI Enhanced Market Trend Forecasts - Newser
How cyclical is Xtant Medical Holdings Inc. stock compared to rivalsTrade Analysis Summary & Scalable Portfolio Growth Ideas - Newser
Why Xtant Medical Holdings Inc. (XMS) stock is trending on social mediaJuly 2025 Summary & Free Safe Entry Trade Signal Reports - Newser
Xtant Medical completes sale of Coflex assets for $19.2 million By Investing.com - Investing.com Canada
Is Xtant Medical Holdings Inc. stock undervalued at current priceJuly 2025 Gainers & Low Drawdown Momentum Trade Ideas - Newser
Companion Spine Acquires Business and Assets of Paradigm Spine GmbH - citybiz
Xtant Medical completes sale of Coflex assets for $19.2 million - Investing.com
Companion Spine acquires Paradigm Spine from Xtant Medical - Investing.com
Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine - Ortho Spine News
Companion Spine acquires Paradigm Spine from Xtant Medical By Investing.com - Investing.com Australia
Companion Spine LLC Completes Acquisition of the Business and Assets of Paradigm Spine GmbH, including the Coflex® and CoFix® Spine Implants and All Other Implant Systems, from Xtant™ Medical Holdings, Inc. - Business Wire
Working capital per share of Xtant Medical Holdings, Inc. – FWB:XMS - TradingView
Book value per share of Xtant Medical Holdings, Inc. – FWB:XMS - TradingView
What analysts say about Xtant Medical Holdings Inc XMS stockHigh Yield Income Stocks & Small Investment Capital Gains - earlytimes.in
How analysts rate Xtant Medical Holdings Inc. stock todayTrade Exit Report & Growth Focused Entry Reports - newser.com
How Xtant Medical Holdings Inc. (XMS) stock stacks up against competitors2025 AllTime Highs & Real-Time Chart Breakout Alerts - newser.com
Is Xtant Medical Holdings Inc. stock in correction or buying zone2025 Top Gainers & High Yield Stock Recommendations - newser.com
Will Xtant Medical Holdings Inc. stock return to pre crash levelsJuly 2025 Action & Risk Managed Trade Strategies - newser.com
Xtant Medical Holdings Inc Stock (XTNT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):